Peter Malfertheiner (P Malfertheiner)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Anti Inflammatory Drugs

Total Hip Arthroplasty

Diffuse Large B Cell Lymphoma

Top Venues

Nature reviews. Disease primers

Alimentary pharmacology & therapeutics

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Mario J Dinis-Ribeiro, Shailja C Shah, Hashem E El-Serag, Matthew Banks, Noriya Uedo, Hisao Tajiri, Luiz Gonzaga Vaz Coelho, Diogo Libânio, Edith Lahner, Antonio Rollan, Jing-Yuan Fang, Leticia Moreira, Jan Bornschein, Peter Malfertheiner, Ernst J Kuipers, Emad M El-Omar
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut (2024)
Peter Malfertheiner, M Constanza Camargo, Emad M El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I Smith, Sebastian Suerbaum
Helicobacter pylori infection. Nature reviews. Disease primers 9 (1) (2023)
Peter Malfertheiner, M Constanza Camargo, Emad M El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I Smith, Sebastian Suerbaum
Helicobacter pylori infection. Nature reviews. Disease primers 9 (1) (2023)
Peter Malfertheiner, Christian Schulz, Colin W Howden
Editorial: PPIs and gastric cancer-Are we dealing with a carcinogen? Alimentary pharmacology & therapeutics 58 (10) (2023)
Massimo Rugge, Robert M Genta, Peter Malfertheiner, David Yates Graham
Atrophic autoimmune gastritis: 'a muddled or misguided core concept compromises our overall comprehension of the problem'. Gut (2023)
Peter Malfertheiner, Francis Mégraud, Theodore Rokkas, Francisco Javier García-Alonso
Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point. Gut (2023)
Peter Malfertheiner, M Constanza Camargo, Emad M El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I Smith, Sebastian Suerbaum
Helicobacter pylori infection. Nature reviews. Disease primers 9 (1) (2023)
Peter Malfertheiner, M Constanza Camargo, Emad M El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I Smith, Sebastian Suerbaum
Helicobacter pylori infection. Nature reviews. Disease primers 9 (1) (2023)
Peter Malfertheiner, M Constanza Camargo, Emad M El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I Smith, Sebastian Suerbaum
Helicobacter pylori infection. Nature reviews. Disease primers 9 (1) (2023)
Massimo Rugge, Robert M Genta, Peter Malfertheiner, David Yates Graham
Gastric cancer risk in autoimmune gastritis: evidence versus opinion. Gut (2023)
Kentaro Sugano, Stuart Jon Spechler, Emad M El-Omar, Kenneth E L McColl, Kaiyo Takubo, Takuji Gotoda, Mitsuhiro Fujishiro, Katsunori Iijima, Haruhiro Inoue, Takashi Kawai, Yoshikazu Kinoshita, Hiroto Miwa, Ken-Ichi Mukaisho, Kazunari Murakami, Yasuyuki Seto, Hisao Tajiri, Shobna Bhatia, Myung-Gyu Choi, Rebecca C Fitzgerald, Kwong Ming Fock, Khean-Lee Goh, Khek Yu Ho, Varocha Mahachai, Maria O'Donovan, Robert Odze, Richard Peek, Massimo Rugge, Prateek Sharma, Jose D Sollano, Michael Vieth, Justin Wu, Ming-Shiang Wu, Duowu Zou, Michio Kaminishi, Peter Malfertheiner
Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction. Gut 71 (8) (2022)
Peter Malfertheiner, Francis Mégraud, Theodore Rokkas, Francisco Javier García-Alonso, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar, null null
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut (2022)
Timothy Wai Ho Shuen, Marianna Alunni-Fabbroni, Elif Öcal, Peter Malfertheiner, Moritz Wildgruber, Regina Schinner, Maciej Pech, Julia Benckert, Bruno Sangro, Christiane K Kuhl, Antonio Gasbarrini, Pierce Kah-Hoe Chow, Han Chong Toh, Jens Ricke
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Jan Bornschein, D Mark Pritchard, Peter Malfertheiner
Letter to the editor: Helicobacter pylori eradication - the proof is not in the symptoms. Gut (2022)
Tim A Labeur, Quincy Hofsink, R Bart Takkenberg, Otto M van Delden, Ron A A Mathôt, Regina Schinner, Peter Malfertheiner, Holger Amthauer, Kerstin Schütte, Bristi Basu, Christiane Kuhl, Julia Mayerle, Jens Ricke, Heinz-Josef Klümpen
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial. Acta oncologica (Stockholm, Sweden) 59 (9) (2020)
Marino Venerito, C Schneider, R Costanzo, R Breja, F-W Röhl, Peter Malfertheiner
Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors. Alimentary pharmacology & therapeutics 47 (11) (2018)
Peter Malfertheiner
Editorial: the non-invasive diagnosis of atrophic gastritis. Alimentary pharmacology & therapeutics 46 (11-12) (2017)